Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-22 2:03 pm Sale | 2023-12-31 | 13G | Innoviva, Inc. INVA | BlackRock Inc. BLK | 10,349,116 16.100% | -262,723 (-2.48%) | Filing History |
| 2023-07-11 08:27 am Unchanged | 2023-07-10 | 13D | Armata Pharmaceuticals, Inc. ARMP | Innoviva Inc. INVA | 64,178,259 85.300% | 0 (Unchanged) | Filing History |
| 2023-05-15 5:05 pm Purchase | 2023-05-11 | 13D | Innoviva, Inc. INVA | Sarissa Capital Management LP | 6,904,000 10.540% | 490,000 (+7.64%) | Filing History |
| 2023-02-14 1:05 pm Purchase | 2022-12-31 | 13G | Innoviva, Inc. INVA | PUTNAM INVESTMENTS LLC | 5,329,107 7.600% | 5,329,107 (New Position) | Filing History |
| 2023-02-13 10:27 am Sale | 2022-12-30 | 13G | Innoviva, Inc. INVA | Renaissance Technologies LLC | 4,229,607 6.060% | -1,065,526 (-20.12%) | Filing History |
| 2023-02-10 2:11 pm Unchanged | 2022-12-31 | 13G | Innoviva, Inc. INVA | BlackRock Inc. BLK | 10,611,839 15.200% | 0 (Unchanged) | Filing History |
| 2023-02-09 11:22 am Purchase | 2022-12-30 | 13G | Innoviva, Inc. INVA | The Vanguard Group | 7,072,212 10.130% | 101,262 (+1.45%) | Filing History |
| 2023-02-01 7:39 pm Purchase | 2022-12-30 | 13G | Innoviva, Inc. INVA | WESTFIELD CAPITAL MANAGEMENT CO LP | 4,106,136 5.880% | 422,651 (+11.47%) | Filing History |
| 2023-01-26 08:52 am Purchase | 2022-12-31 | 13G | Innoviva, Inc. INVA | BlackRock Inc. BLK | 10,611,839 10.600% | 4,940,739 (+87.12%) | Filing History |
| 2023-01-20 5:17 pm Sale | 2022-12-31 | 13G | Innoviva, Inc. INVA | BlackRock Inc. BLK | 5,671,100 10.600% | -3,337,658 (-37.05%) | Filing History |
| 2023-01-10 5:12 pm Purchase | 2023-01-10 | 13D | Armata Pharmaceuticals, Inc. ARMP | Innoviva Inc. INVA | 64,178,259 85.300% | 19,736,843 (+44.41%) | Filing History |
| 2022-07-11 5:27 pm Sale | 2022-07-07 | 13D | Armata Pharmaceuticals, Inc. ARMP | Innoviva Inc. INVA | 100 100.000% | -57,345,694 (-100.00%) | Filing History |
| 2022-07-11 1:13 pm Purchase | 2022-06-30 | 13G | Innoviva, Inc. INVA | The Vanguard Group | 6,970,950 10.000% | 170,755 (+2.51%) | Filing History |
| 2022-05-23 8:55 pm Unchanged | 2022-05-23 | 13D | Armata Pharmaceuticals, Inc. ARMP | Innoviva Inc. INVA | 57,345,794 74.930% | 0 (Unchanged) | Filing History |
| 2022-04-01 4:50 pm Purchase | 2022-03-31 | 13D | Armata Pharmaceuticals, Inc. ARMP | Innoviva Inc. INVA | 44,441,416 80.100% | 8,077,812 (+22.21%) | Filing History |
| 2022-03-15 09:00 am Unchanged | 2022-03-15 | 13D | Armata Pharmaceuticals, Inc. ARMP | Innoviva Inc. INVA | 57,345,794 74.930% | 0 (Unchanged) | Filing History |
| 2022-02-18 8:47 pm Unchanged | 2022-02-17 | 13D | Armata Pharmaceuticals, Inc. ARMP | Innoviva Inc. INVA | 57,345,794 75.150% | 0 (Unchanged) | Filing History |
| 2022-02-11 3:15 pm Purchase | 2022-02-09 | 13D | Armata Pharmaceuticals, Inc. ARMP | Innoviva Inc. INVA | 36,363,604 76.700% | 5,422,188 (+17.52%) | Filing History |
| 2022-02-11 2:10 pm Sale | 2021-12-31 | 13G | Innoviva, Inc. INVA | Renaissance Technologies LLC | 5,295,133 7.620% | -2,196,209 (-29.32%) | Filing History |
| 2022-02-10 08:17 am Purchase | 2021-12-31 | 13G | Innoviva, Inc. INVA | The Vanguard Group | 6,800,195 9.790% | 204,712 (+3.10%) | Filing History |